Compass Pathways: Psychedelics Pioneer episode artwork

EPISODE · Apr 24, 2026 · 1 MIN

Compass Pathways: Psychedelics Pioneer

from The Daily News Now! Business

President Trumps executive order expedites psychedelic therapies FDA approvals, boosting Compass Pathways (CMPS) stock. CMPS leads with COMP three sixty, a synthetic psilocybin for depression, boasting positive phase three data and a strong cash position, positioning them as the psychedelics frontrunner. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/71f9ee006a6e526a

NOW PLAYING

Compass Pathways: Psychedelics Pioneer

0:00 1:46

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Daily News Now! Business?

This episode is 1 minute long.

When was this The Daily News Now! Business episode published?

This episode was published on April 24, 2026.

What is this episode about?

President Trumps executive order expedites psychedelic therapies FDA approvals, boosting Compass Pathways (CMPS) stock. CMPS leads with COMP three sixty, a synthetic psilocybin for depression, boasting positive phase three data and a strong...

Can I download this The Daily News Now! Business episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!